全文获取类型
收费全文 | 7822篇 |
免费 | 754篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 94篇 |
儿科学 | 260篇 |
妇产科学 | 145篇 |
基础医学 | 1048篇 |
口腔科学 | 201篇 |
临床医学 | 835篇 |
内科学 | 1755篇 |
皮肤病学 | 155篇 |
神经病学 | 800篇 |
特种医学 | 204篇 |
外国民族医学 | 2篇 |
外科学 | 1109篇 |
综合类 | 74篇 |
一般理论 | 2篇 |
预防医学 | 728篇 |
眼科学 | 133篇 |
药学 | 412篇 |
中国医学 | 14篇 |
肿瘤学 | 632篇 |
出版年
2023年 | 47篇 |
2022年 | 78篇 |
2021年 | 235篇 |
2020年 | 112篇 |
2019年 | 276篇 |
2018年 | 306篇 |
2017年 | 213篇 |
2016年 | 203篇 |
2015年 | 227篇 |
2014年 | 284篇 |
2013年 | 390篇 |
2012年 | 478篇 |
2011年 | 454篇 |
2010年 | 298篇 |
2009年 | 241篇 |
2008年 | 382篇 |
2007年 | 402篇 |
2006年 | 376篇 |
2005年 | 349篇 |
2004年 | 273篇 |
2003年 | 262篇 |
2002年 | 290篇 |
2001年 | 179篇 |
2000年 | 202篇 |
1999年 | 177篇 |
1998年 | 68篇 |
1997年 | 77篇 |
1996年 | 55篇 |
1995年 | 57篇 |
1994年 | 49篇 |
1993年 | 40篇 |
1992年 | 142篇 |
1991年 | 157篇 |
1990年 | 128篇 |
1989年 | 131篇 |
1988年 | 119篇 |
1987年 | 99篇 |
1986年 | 111篇 |
1985年 | 74篇 |
1984年 | 67篇 |
1983年 | 54篇 |
1981年 | 27篇 |
1980年 | 25篇 |
1979年 | 50篇 |
1977年 | 28篇 |
1976年 | 29篇 |
1974年 | 23篇 |
1973年 | 34篇 |
1970年 | 23篇 |
1969年 | 24篇 |
排序方式: 共有8603条查询结果,搜索用时 906 毫秒
161.
Desiree M.J. Dorleijn Pim A.J. Luijsterburg Sita M.A. Bierma-Zeinstra Pieter K. Bos 《The Journal of arthroplasty》2014
To assess the diagnostic value of intra-articular anesthetic hip injection in patients with hip pain atypical for osteoarthritis (OA), literature was searched. Included were studies assessing the diagnostic value of anesthetic hip injections in differentiating between pain caused by OA or another source. Pooled estimates of sensitivity and specificity with 95% confidence intervals (CI) were calculated. Of the 1387 potentially eligible articles, nine case series with high risk of bias could be included. The pooled sensitivity was 0.97 (95% CI 0.87, 0.99). Specificity was 0.91 (95% CI 0.83, 0.95). For clinical practice, no recommendation can be made regarding the use of hip injections for diagnosing hip OA. High quality, accurately reported studies are needed to provide better evidence on the diagnostic role of hip injection. 相似文献
162.
Nicole E Lopez Cristina Prendergast Andrew M Lowy 《World journal of gastroenterology : WJG》2014,20(31):10740-10751
Pancreatic cancer is the fourth leading cause of cancer death in the United States. While surgical resection remains the only curative option, more than 80% of patients present with unresectable disease. Unfortunately, even among those who undergo resection, the reported median survival is 15-23 mo, with a 5-year survival of approximately 20%. Disappointingly, over the past several decades, despite improvements in diagnostic imaging, surgical technique and chemotherapeutic options, only modest improvements in survival have been realized. Nevertheless, it remains clear that surgical resection is a prerequisite for achieving long-term survival and cure. There is now emerging consensus that a subgroup of patients, previously considered poor candidates for resection because of the relationship of their primary tumor to surrounding vasculature, may benefit from resection, particularly when preceded by neoadjuvant therapy. This stage of disease, termed borderline resectable pancreatic cancer, has become of increasing interest and is now the focus of a multi-institutional clinical trial. Here we outline the history, progress, current treatment recommendations, and future directions for research in borderline resectable pancreatic cancer. 相似文献
163.
A. Feinberg P. M. Lopez K. Wyka N. Islam L. Seidl E. Drackett A. Mata J. Pinzon M. R. Baker J. Lopez C. Trinh-Shevrin D. Shelley Z. Bailey K. A. Maybank L. E. Thorpe 《Journal of urban health》2017,94(4):525-533
To guide targeted cessation and prevention programming, this study assessed smoking prevalence and described sociodemographic, health, and healthcare use characteristics of adult smokers in public housing. Self-reported data were analyzed from a random sample of 1664 residents aged 35 and older in ten New York City public housing developments in East/Central Harlem. Smoking prevalence was 20.8%. Weighted log-binomial models identified to be having Medicaid, not having a personal doctor, and using health clinics for routine care were positively associated with smoking. Smokers without a personal doctor were less likely to receive provider quit advice. While most smokers in these public housing developments had health insurance, a personal doctor, and received provider cessation advice in the last year (72.4%), persistently high smoking rates suggest that such cessation advice may be insufficient. Efforts to eliminate differences in tobacco use should consider place-based smoking cessation interventions that extend cessation support beyond clinical settings. 相似文献
164.
165.
166.
167.
Maria José Magalhães Patricia Alonso Ruido Rita DeOliveira Braga Lopez 《Health care for women international》2016,37(12):1304-1319
In this article, we explore professionals' representations of elderly female victims of gender violence. Semi-structured interviews were used to explore seven professionals' work philosophies and intervention methodologies in their work with elderly female victims of violence, their main problems and difficulties, and their perspectives regarding shelters for elderly women. Results show that there are no specific philosophies and methodologies to intervene with these victims. There is a tendency to homogenize all the victims of gender violence, regardless of their age and specific needs. The professionals also tended to trivialize gender violence against elderly female victims, considering that these women tolerate violence. 相似文献
168.
A. Torres F. Lopez Boo V. Parra C. Vazquez S. Segura‐Pérez Z. Cetin R. Pérez‐Escamilla 《Child: care, health and development》2018,44(1):4-11
Background
Chile Crece Contigo (ChCC) is defined as a comprehensive, intersectoral, and multicomponent policy that aims to help all children reach their full potential for development, regardless of their socio‐economic status.Methods
This case study was developed on the basis of grey literature review and key informants' interviews.Results
ChCC behaves as a complex adaptive system that combines universal and targeted benefits for the more vulnerable starting since gestation and until the children are 4 years old. Three key ministries are involved in ChCC management: health, education, and social development. Studies show adequate programme implementation and positive effects of ChCC on child development. In addition, it was found that the more families use ChCC benefits and the longer the subsystem has been operating in the commune, the greater the positive effects.Conclusions
Strong political support based on principles of equity and child rights combined with strong evidence and funding commitment from government has been central to emergence, scaling up, and sustainability of ChCC. Further sustainability of ChCC will rely on firmly establishing a well‐trained and compensated cadre of early child development professionals and paraprofessionals as well as an improved management and evaluation decentralized system. 相似文献169.
170.
To investigate low‐level laser therapy (LLLT) applied to treat burning mouth syndrome (BMS). This prospective, comparative, partially blinded, single‐centre, clinical trial of GaAlAs Laser, with 815 nm wavelength, included 44 BMS patients divided randomly into three groups: Group I (n = 16): GaAlAs laser 815 nm wavelength, 1 W output power, continuous emissions, 4 s, 4 J and fluence rate 133·3 J cm?2; Group II (n = 16): GaAlAs infrared laser, 815 nm wavelength, 1 W output power, continuous emissions, 6 s, 6 J and fluence rate 200 J cm?2; Group III (n = 12) placebo group, sham laser. All groups received a weekly dose for 4 weeks. Pain intensity was recorded using a 10‐cm visual analogue scale; patients responded to the oral health impact profile (OHIP‐14), xerostomia severity test and the hospital anxiety–depression scale (HAD). These assessments were performed at baseline, 2 and 4 weeks. LLLT decreased pain intensity and improved OHIP‐14 scores significantly from baseline to 2 weeks in groups I and II compared with the placebo group. No statistically significant differences were found from 2 to 4 weeks. Overall improvements in visual analogue scale (VAS) scores from baseline to the end of treatment were as follows: Group I 15·7%; Group II 15·6%; Group III placebo 7·3%. LLLT application reduces symptoms slightly in BMS patients. 相似文献